Skip to main content
Clinical Trials/NL-OMON34558
NL-OMON34558CompletedNot Applicable

Identification of psychometric and biological markers to assess androgen and serotonergic sensitivity in relation to sexual functioning in women. - Androgen sensitivity in women.

Emotional Brain0 sites200 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
200

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • 1. Provision of written informed consent;
  • 2. Female 21-70 years of age;
  • 3. Healthy according to normal results of medical history
  • 4. Subject must be heterosexually oriented;
  • 5. BMI >= 18 and <= 30 kg/m2;
  • 6. Dutch as first language;

Exclusion Criteria

  • 1. Subjects who have had hand surgery interfering with measurement of digit lengths;
  • 2. Subjects with musculoskeletal conditions affecting the measurements of digit lengths;
  • 3. Known conditions associated with abnormal prenatal androgen exposure, namely congenital adrenal hyperplasia and complete androgen insensitivity syndrome;
  • 4. Positive drug test and/or positive alcohol test;
  • 5. Subjects with dyslexia;
  • 6. Subjects who are color-blind;
  • 7. Positive urine pregnancy test;
  • 8. Use of oral contraception containing anti-androgens (e.g. Diane 35; Minerva);
  • 9. Use of oral contraception containing 50 µg estrogen or more;
  • 10. Homosexual orientation.

Investigators

Similar Trials

Identification of psychometric and... | Clinical Trial